| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | cyclosporin A binding | 2.20e-06 | 24 | 182 | 5 | GO:0016018 | |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent conferring tensile strength | 3.65e-06 | 46 | 182 | 6 | GO:0030020 | |
| GeneOntologyMolecularFunction | opsonin binding | 7.27e-05 | 25 | 182 | 4 | GO:0001846 | |
| GeneOntologyMolecularFunction | complement component C1q complex binding | 8.53e-05 | 10 | 182 | 3 | GO:0001849 | |
| GeneOntologyMolecularFunction | peptidyl-prolyl cis-trans isomerase activity | 9.05e-05 | 50 | 182 | 5 | GO:0003755 | |
| GeneOntologyMolecularFunction | cis-trans isomerase activity | 1.20e-04 | 53 | 182 | 5 | GO:0016859 | |
| GeneOntologyMolecularFunction | complement binding | 1.97e-04 | 32 | 182 | 4 | GO:0001848 | |
| GeneOntologyMolecularFunction | oxidoreductase activity | ALKBH4 MICAL1 CYP2C18 MAOA CYP2F1 GPX8 ACAD9 PARK7 PYROXD2 RDH5 ALDH1L1 NDUFB6 CRYL1 ALDH1A2 TPH2 ALDH9A1 G6PD CYB5R1 | 2.31e-04 | 766 | 182 | 18 | GO:0016491 |
| GeneOntologyMolecularFunction | antiporter activity | 2.77e-04 | 138 | 182 | 7 | GO:0015297 | |
| GeneOntologyMolecularFunction | aldehyde dehydrogenase (NAD+) activity | 3.13e-04 | 15 | 182 | 3 | GO:0004029 | |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 3.37e-04 | 188 | 182 | 8 | GO:0005201 | |
| GeneOntologyMolecularFunction | secondary active transmembrane transporter activity | SLC24A5 SLC35E2B SLC30A2 SLC38A2 SLC30A5 SLC12A2 SLC24A4 SLC22A8 SLC37A2 CTNS | 4.00e-04 | 296 | 182 | 10 | GO:0015291 |
| GeneOntologyMolecularFunction | aldehyde dehydrogenase [NAD(P)+] activity | 4.61e-04 | 17 | 182 | 3 | GO:0004030 | |
| GeneOntologyMolecularFunction | metal cation:monoatomic cation antiporter activity | 6.24e-04 | 43 | 182 | 4 | GO:0140828 | |
| GeneOntologyMolecularFunction | calcium, potassium:sodium antiporter activity | 8.11e-04 | 5 | 182 | 2 | GO:0008273 | |
| GeneOntologyMolecularFunction | zinc:proton antiporter activity | 8.11e-04 | 5 | 182 | 2 | GO:0140826 | |
| GeneOntologyBiologicalProcess | organophosphate metabolic process | PITPNM2 COL6A1 DPYS CAD HK1 ACACB PARK7 ALDH1L1 NDUFB6 PLA2G15 FCSK CRYL1 SLC30A5 PMVK P2RX7 LIPG NT5C2 GPCPD1 SLC37A2 PLA2G6 XYLB PLCG2 CTNS PLD2 G6PD ENTPD8 | 6.30e-06 | 1142 | 179 | 26 | GO:0019637 |
| GeneOntologyBiologicalProcess | organophosphate catabolic process | COL6A1 DPYS HK1 PLA2G15 P2RX7 LIPG NT5C2 GPCPD1 PLA2G6 PLCG2 PLD2 ENTPD8 | 6.66e-06 | 281 | 179 | 12 | GO:0046434 |
| GeneOntologyBiologicalProcess | phospholipid catabolic process | 1.33e-05 | 60 | 179 | 6 | GO:0009395 | |
| GeneOntologyBiologicalProcess | protein peptidyl-prolyl isomerization | 1.85e-05 | 38 | 179 | 5 | GO:0000413 | |
| GeneOntologyCellularComponent | anchoring collagen complex | 6.49e-07 | 3 | 182 | 3 | GO:0030934 | |
| GeneOntologyCellularComponent | collagen trimer | 1.20e-04 | 88 | 182 | 6 | GO:0005581 | |
| MousePheno | decreased bone mineralization | 1.08e-05 | 51 | 139 | 6 | MP:0020137 | |
| Domain | VWF_A | 4.56e-06 | 99 | 177 | 8 | IPR002035 | |
| Domain | - | 6.43e-06 | 74 | 177 | 7 | 3.40.50.410 | |
| Domain | VWFA | 1.27e-05 | 82 | 177 | 7 | PS50234 | |
| Domain | VWA | 1.49e-05 | 84 | 177 | 7 | SM00327 | |
| Domain | Cyclophilin-type_PPIase_CS | 2.70e-05 | 19 | 177 | 4 | IPR020892 | |
| Domain | Cyclophilin-type_PPIase | 4.11e-05 | 21 | 177 | 4 | IPR024936 | |
| Domain | Pro_isomerase | 4.99e-05 | 22 | 177 | 4 | PF00160 | |
| Domain | Cyclophilin-type_PPIase_dom | 4.99e-05 | 22 | 177 | 4 | IPR002130 | |
| Domain | Cyclophilin-like_dom | 4.99e-05 | 22 | 177 | 4 | IPR029000 | |
| Domain | CSA_PPIASE_2 | 4.99e-05 | 22 | 177 | 4 | PS50072 | |
| Domain | - | 4.99e-05 | 22 | 177 | 4 | 2.40.100.10 | |
| Domain | CSA_PPIASE_1 | 4.99e-05 | 22 | 177 | 4 | PS00170 | |
| Domain | Collagen | 1.57e-04 | 85 | 177 | 6 | IPR008160 | |
| Domain | Collagen | 1.57e-04 | 85 | 177 | 6 | PF01391 | |
| Domain | VWA | 1.87e-04 | 56 | 177 | 5 | PF00092 | |
| Domain | - | 2.88e-04 | 95 | 177 | 6 | 2.60.120.200 | |
| Domain | Ald_DH_CS_GLU | 4.28e-04 | 16 | 177 | 3 | IPR029510 | |
| Domain | Ald_DH_CS_CYS | 5.16e-04 | 17 | 177 | 3 | IPR016160 | |
| Domain | ALDEHYDE_DEHYDR_CYS | 6.15e-04 | 18 | 177 | 3 | PS00070 | |
| Domain | ALDEHYDE_DEHYDR_GLU | 6.15e-04 | 18 | 177 | 3 | PS00687 | |
| Domain | - | 7.25e-04 | 19 | 177 | 3 | 3.40.605.10 | |
| Domain | Aldedh | 7.25e-04 | 19 | 177 | 3 | PF00171 | |
| Domain | Ald_DH_C | 7.25e-04 | 19 | 177 | 3 | IPR016163 | |
| Domain | Ald_DH_N | 7.25e-04 | 19 | 177 | 3 | IPR016162 | |
| Domain | Ald_DH/histidinol_DH | 7.25e-04 | 19 | 177 | 3 | IPR016161 | |
| Domain | Aldehyde_DH_dom | 7.25e-04 | 19 | 177 | 3 | IPR015590 | |
| Domain | - | 7.25e-04 | 19 | 177 | 3 | 3.40.309.10 | |
| Domain | PQ-loop | 8.76e-04 | 5 | 177 | 2 | PF04193 | |
| Domain | Anaphylatoxin_comp_syst | 8.76e-04 | 5 | 177 | 2 | IPR018081 | |
| Domain | Anaphylatoxn_comp_syst_dom | 8.76e-04 | 5 | 177 | 2 | IPR001840 | |
| Domain | CTNS | 8.76e-04 | 5 | 177 | 2 | SM00679 | |
| Domain | CPSASE_1 | 8.76e-04 | 5 | 177 | 2 | PS00866 | |
| Domain | K/Na/Ca-exchanger | 8.76e-04 | 5 | 177 | 2 | IPR004481 | |
| Domain | PQ-loop_rpt | 8.76e-04 | 5 | 177 | 2 | IPR006603 | |
| Domain | ConA-like_dom | 1.18e-03 | 219 | 177 | 8 | IPR013320 | |
| Domain | TSPN | 1.29e-03 | 23 | 177 | 3 | SM00210 | |
| Domain | EPTP | 1.31e-03 | 6 | 177 | 2 | PF03736 | |
| Domain | EPTP | 1.31e-03 | 6 | 177 | 2 | IPR005492 | |
| Domain | Integrin_b_cyt | 1.31e-03 | 6 | 177 | 2 | SM01241 | |
| Domain | Integrin_b_cyt | 1.31e-03 | 6 | 177 | 2 | PF08725 | |
| Domain | Integrin_bsu_cyt_dom | 1.31e-03 | 6 | 177 | 2 | IPR014836 | |
| Domain | CPSASE_2 | 1.31e-03 | 6 | 177 | 2 | PS00867 | |
| Domain | Integrin_dom | 1.65e-03 | 25 | 177 | 3 | IPR032695 | |
| Domain | ANATO | 1.82e-03 | 7 | 177 | 2 | SM00104 | |
| Domain | CbamoylP_synth_lsu-like_ATP-bd | 1.82e-03 | 7 | 177 | 2 | IPR005479 | |
| Domain | ANAPHYLATOXIN_2 | 1.82e-03 | 7 | 177 | 2 | PS01178 | |
| Domain | ANAPHYLATOXIN_1 | 1.82e-03 | 7 | 177 | 2 | PS01177 | |
| Domain | BC-like_N | 1.82e-03 | 7 | 177 | 2 | IPR005481 | |
| Domain | Integrin_B_tail | 1.82e-03 | 7 | 177 | 2 | SM01242 | |
| Domain | EAR | 1.82e-03 | 7 | 177 | 2 | IPR009039 | |
| Domain | ANATO | 1.82e-03 | 7 | 177 | 2 | PF01821 | |
| Domain | EAR | 1.82e-03 | 7 | 177 | 2 | PS50912 | |
| Domain | Integrin_bsu_tail | 1.82e-03 | 7 | 177 | 2 | IPR012896 | |
| Domain | CPSase_L_D2 | 1.82e-03 | 7 | 177 | 2 | PF02786 | |
| Domain | Biotin_carb_N | 1.82e-03 | 7 | 177 | 2 | PF00289 | |
| Domain | Anaphylatoxin/fibulin | 1.82e-03 | 7 | 177 | 2 | IPR000020 | |
| Domain | Integrin_B_tail | 1.82e-03 | 7 | 177 | 2 | PF07965 | |
| Domain | Laminin_G | 2.22e-03 | 58 | 177 | 4 | IPR001791 | |
| Domain | MacrogloblnA2_thiol-ester-bond | 2.41e-03 | 8 | 177 | 2 | IPR019565 | |
| Domain | INB | 2.41e-03 | 8 | 177 | 2 | SM00187 | |
| Domain | Integrin_bsu_VWA | 2.41e-03 | 8 | 177 | 2 | IPR002369 | |
| Domain | - | 2.41e-03 | 8 | 177 | 2 | 2.60.40.360 | |
| Domain | Calx_beta | 2.41e-03 | 8 | 177 | 2 | SM00237 | |
| Domain | Integrin_beta | 2.41e-03 | 8 | 177 | 2 | PF00362 | |
| Domain | Thiol-ester_cl | 2.41e-03 | 8 | 177 | 2 | PF10569 | |
| Domain | MacrogloblnA2_CS | 2.41e-03 | 8 | 177 | 2 | IPR019742 | |
| Pathway | REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES | 1.70e-06 | 61 | 134 | 7 | M27103 | |
| Pathway | REACTOME_COLLAGEN_FORMATION | 2.18e-06 | 90 | 134 | 8 | M631 | |
| Pathway | REACTOME_COLLAGEN_CHAIN_TRIMERIZATION | 2.26e-06 | 41 | 134 | 6 | MM15538 | |
| Pathway | REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES | 3.24e-06 | 67 | 134 | 7 | M26999 | |
| Pathway | REACTOME_COLLAGEN_CHAIN_TRIMERIZATION | 3.46e-06 | 44 | 134 | 6 | M27812 | |
| Pathway | PID_SYNDECAN_1_PATHWAY | 4.52e-06 | 46 | 134 | 6 | M198 | |
| Pathway | REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES | 7.43e-06 | 50 | 134 | 6 | MM14796 | |
| Pathway | REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES | 2.38e-05 | 61 | 134 | 6 | MM14637 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | COL6A1 COL7A1 COL11A1 HTRA1 COL12A1 COL6A6 ITGA6 PPIB ITGB2 ITGB7 HAPLN1 COL14A1 | 2.88e-05 | 300 | 134 | 12 | M610 |
| Pathway | REACTOME_COLLAGEN_DEGRADATION | 3.15e-05 | 64 | 134 | 6 | M26953 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | COL6A1 COL7A1 COL11A1 HTRA1 COL12A1 COL6A6 ITGA6 ITGB2 ITGB7 HAPLN1 COL14A1 | 3.52e-05 | 258 | 134 | 11 | MM14572 |
| Pathway | KEGG_PYRIMIDINE_METABOLISM | 4.04e-05 | 98 | 134 | 7 | M5109 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 8.36e-05 | 76 | 134 | 6 | MM14867 | |
| Pathway | REACTOME_COLLAGEN_FORMATION | 8.36e-05 | 76 | 134 | 6 | MM14573 | |
| Pathway | REACTOME_COLLAGEN_DEGRADATION | 1.43e-04 | 53 | 134 | 5 | MM14566 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 1.56e-04 | 85 | 134 | 6 | M16441 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 3.77e-04 | 140 | 134 | 7 | M587 | |
| Pubmed | Large-scale proteomics and phosphoproteomics of urinary exosomes. | COL6A1 FLNB DPYS LRRC57 NEBL UACA PARK7 APCS ALDH1L1 ADGRV1 PKD1L3 PPIB RYR1 CRYL1 MYOF PMVK SLC22A8 RNPEP PRKCH CTNS ALDH9A1 SCIN G6PD | 4.25e-09 | 1016 | 182 | 23 | 19056867 |
| Pubmed | In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine. | PAPPA2 CRISPLD2 COL6A1 FLNB FAT4 NIBAN1 PPIAL4C LRRC57 MAN2B1 PARK7 APCS ALDH1L1 PPIB PLA2G15 CRYL1 MYOF RNPEP PPIAL4A C4A C4B ALDH9A1 G6PD CDH15 | 1.11e-08 | 1070 | 182 | 23 | 23533145 |
| Pubmed | 1.53e-08 | 32 | 182 | 6 | 23154389 | ||
| Pubmed | 1.41e-07 | 3 | 182 | 3 | 23624502 | ||
| Pubmed | FLNB CAD COL12A1 MAN2B1 GPX8 RPS3 ACAD9 PARK7 DLGAP5 TYSND1 PLXNB2 NDUFB6 DRG1 WDR3 SLC38A2 MYOF RNPEP MDC1 NT5C2 ALDH9A1 G6PD PCM1 SYNCRIP | 3.50e-07 | 1297 | 182 | 23 | 33545068 | |
| Pubmed | Comprehensive proteomic characterization of stem cell-derived extracellular matrices. | 3.63e-07 | 86 | 182 | 7 | 28327460 | |
| Pubmed | FLNB CAD HK1 POLR1A ZCCHC8 HNRNPF WDR3 UTP18 RNPEP MDC1 RBM6 KMT2A HERC2 PCM1 USP47 SYNCRIP | 3.93e-07 | 653 | 182 | 16 | 22586326 | |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | POLR1A ACACB COL6A6 ACAD9 POLD1 ALDH1L1 PPIB KMT2A C4A C4B DNAI7 G6PD TBL2 HYDIN | 4.17e-07 | 497 | 182 | 14 | 36774506 |
| Pubmed | Proteomics characterization of extracellular space components in the human aorta. | 1.09e-06 | 101 | 182 | 7 | 20551380 | |
| Pubmed | 1.10e-06 | 146 | 182 | 8 | 27068509 | ||
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | FLNB CAD HK1 RPS3 PARK7 ALDH1L1 PPIB HNRNPF RYR1 EFTUD2 MYOF SLC12A2 NT5C2 KMT2A G6PD HYDIN SYNCRIP | 1.35e-06 | 807 | 182 | 17 | 30575818 |
| Pubmed | Competitive binding of E3 ligases TRIM26 and WWP2 controls SOX2 in glioblastoma. | COL11A1 HK1 PARK7 PABPC4L HNRNPF RYR1 UTP18 PMVK KIAA1217 PPIAL4A RAB39A C4A HAL ALDH9A1 G6PD TBL2 | 1.74e-06 | 732 | 182 | 16 | 34732716 |
| Pubmed | FLNB CAD UACA ZCCHC8 RPS3 PPP1R9A HNRNPF EFTUD2 RBM6 SYNCRIP | 2.03e-06 | 274 | 182 | 10 | 34244482 | |
| Pubmed | FAT4 CAD FRMPD4 RPS3 HNRNPF EFTUD2 LIPG KIAA1217 MDC1 PLA2G6 HERC2 SCIN SYNCRIP | 3.49e-06 | 513 | 182 | 13 | 25798074 | |
| Pubmed | CYLD CAD HK1 UACA ACAD9 POLD1 PARK7 PLXNB2 PPIB DRG1 EFTUD2 WDR3 SLC38A2 UTP18 SLC12A2 PDZD8 COL14A1 TMEM131 HERC2 ALDH9A1 TBL2 PCM1 SYNCRIP | 3.54e-06 | 1487 | 182 | 23 | 33957083 | |
| Pubmed | PITPNM2 MICAL1 FLNB HTRA1 CAD HK1 RPS3 PARK7 PPP1R9A ALDH1L1 PPIB SHANK3 HNRNPF HAPLN1 RNPEP KIAA1217 LGI3 KMT2A C4A C4B PCM1 SYNCRIP | 6.46e-06 | 1431 | 182 | 22 | 37142655 | |
| Pubmed | Extracellular matrix secretion by cardiac fibroblasts: role of microRNA-29b and microRNA-30c. | 6.98e-06 | 248 | 182 | 9 | 24006456 | |
| Pubmed | 7.10e-06 | 24 | 182 | 4 | 25344368 | ||
| Pubmed | Characterization of the Extracellular Matrix of Normal and Diseased Tissues Using Proteomics. | 7.54e-06 | 135 | 182 | 7 | 28675934 | |
| Pubmed | 7.74e-06 | 8 | 182 | 3 | 18816857 | ||
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | FLNB NIBAN1 CAD POLR1A RPS3 PPP1R9A PLXNB2 PPIB HNRNPF DRG1 EFTUD2 WDR3 SLC12A2 MDC1 HERC2 SCIN PCM1 SYNCRIP | 8.06e-06 | 1024 | 182 | 18 | 24711643 |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | FLNB CAD MIS18BP1 HK1 POLR1A GPX8 RPS3 POLD1 PARK7 DLGAP5 PPIB HNRNPF EFTUD2 WDR3 UTP18 MDC1 PLCG2 HERC2 ALDH9A1 G6PD SYNCRIP | 9.23e-06 | 1353 | 182 | 21 | 29467282 |
| Pubmed | 9.76e-06 | 196 | 182 | 8 | 19334288 | ||
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | KDELR2 CAD MIS18BP1 HK1 MAOA ZCCHC8 ACAD9 PLXNB2 NFU1 WDR3 UTP18 SLC12A2 KIAA1217 ELAVL2 PDZD8 PRKCH TMEM131 HERC2 TBL2 USP47 CYB5R1 SYNCRIP | 1.29e-05 | 1496 | 182 | 22 | 32877691 |
| Pubmed | NIBAN1 CAD RPS3 POLD1 TYSND1 PPIB ITGB2 ITGB7 HNRNPF DRG1 EFTUD2 KSR1 PMVK PDZD8 HERC2 G6PD PCM1 CYB5R1 SYNCRIP | 1.33e-05 | 1168 | 182 | 19 | 19946888 | |
| Pubmed | CYLD CAD UACA PARK7 PPP1R9A DLGAP5 HECTD4 PPIB PLA2G15 SHANK3 EFTUD2 P2RX7 KIAA1217 NT5C2 ELAVL2 HERC2 PCM1 | 1.38e-05 | 963 | 182 | 17 | 28671696 | |
| Pubmed | 1.61e-05 | 210 | 182 | 8 | 16537572 | ||
| Pubmed | Genetic determinants of hair, eye and skin pigmentation in Europeans. | 1.65e-05 | 10 | 182 | 3 | 17952075 | |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | COL6A1 COL7A1 FAT4 HTRA1 COL12A1 MAN2B1 GPX8 ITGA6 PLXNB2 PPIB PLA2G15 DRG1 SLC38A2 MYOF SLC12A2 C4A TMEM131 G6PD AMIGO2 | 1.95e-05 | 1201 | 182 | 19 | 35696571 |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | FLNB CAD HK1 POLR1A RPS3 ACAD9 POLD1 PARK7 PPIB PLA2G15 HNRNPF DRG1 EFTUD2 WDR3 SLC38A2 UTP18 RNPEP MDC1 DNAH5 G6PD SYNCRIP | 1.99e-05 | 1425 | 182 | 21 | 30948266 |
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | CYLD FLNB POLR1A ACAD9 PARK7 PPP1R9A POLR2G TYSND1 PPIB EFTUD2 WDR3 UTP18 KLHL15 HERC2 ALDH9A1 TBL2 USP47 | 2.37e-05 | 1005 | 182 | 17 | 19615732 |
| Pubmed | 2.72e-05 | 2 | 182 | 2 | 22737222 | ||
| Pubmed | Deficiency of C4 from donor or recipient mouse fails to prevent renal allograft rejection. | 2.72e-05 | 2 | 182 | 2 | 16565498 | |
| Pubmed | 2.72e-05 | 2 | 182 | 2 | 15998580 | ||
| Pubmed | 2.72e-05 | 2 | 182 | 2 | 19062096 | ||
| Pubmed | 2.72e-05 | 2 | 182 | 2 | 15609093 | ||
| Pubmed | 2.72e-05 | 2 | 182 | 2 | 30419947 | ||
| Pubmed | Activation of innate and humoral immunity in the peripheral nervous system of ALS transgenic mice. | 2.72e-05 | 2 | 182 | 2 | 19933335 | |
| Pubmed | Structural basis for the C4d.1/C4d.2 serologic allotypes of murine complement component C4. | 2.72e-05 | 2 | 182 | 2 | 2459207 | |
| Pubmed | Antigen-induced B cell apoptosis is independent of complement C4. | 2.72e-05 | 2 | 182 | 2 | 17645767 | |
| Pubmed | 2.72e-05 | 2 | 182 | 2 | 12207352 | ||
| Pubmed | Complement C4A and C4B Gene Copy Number Study in Alzheimer's Disease Patients. | 2.72e-05 | 2 | 182 | 2 | 27758680 | |
| Pubmed | 2.72e-05 | 2 | 182 | 2 | 22387014 | ||
| Pubmed | 2.72e-05 | 2 | 182 | 2 | 22498810 | ||
| Pubmed | 2.72e-05 | 2 | 182 | 2 | 23340173 | ||
| Pubmed | Unsaturated fatty acids phosphorylate and destabilize ABCA1 through a phospholipase D2 pathway. | 2.72e-05 | 2 | 182 | 2 | 16118212 | |
| Pubmed | Complement C4 maintains peripheral B-cell tolerance in a myeloid cell dependent manner. | 2.72e-05 | 2 | 182 | 2 | 23749435 | |
| Pubmed | 2.72e-05 | 2 | 182 | 2 | 23918728 | ||
| Pubmed | Molecular genetics of androgen-dependent and -independent expression of mouse sex-limited protein. | 2.72e-05 | 2 | 182 | 2 | 3037333 | |
| Pubmed | 2.72e-05 | 2 | 182 | 2 | 11726230 | ||
| Pubmed | 2.72e-05 | 2 | 182 | 2 | 4216347 | ||
| Pubmed | Sequence determination of the thiolester site of the fourth component of human complement. | 2.72e-05 | 2 | 182 | 2 | 6950384 | |
| Pubmed | 2.72e-05 | 2 | 182 | 2 | 8660986 | ||
| Pubmed | Tissue-specific RNA processing for the complement C4 gene transcript in the H-2k mouse strain. | 2.72e-05 | 2 | 182 | 2 | 8428773 | |
| Pubmed | 2.72e-05 | 2 | 182 | 2 | 24638111 | ||
| Pubmed | Transcriptional repression of C4 complement by hepatitis C virus proteins. | 2.72e-05 | 2 | 182 | 2 | 21345967 | |
| Pubmed | 2.72e-05 | 2 | 182 | 2 | 31273343 | ||
| Pubmed | 2.72e-05 | 2 | 182 | 2 | 2572548 | ||
| Pubmed | 2.72e-05 | 2 | 182 | 2 | 2302180 | ||
| Pubmed | 2.72e-05 | 2 | 182 | 2 | 24991767 | ||
| Pubmed | 2.72e-05 | 2 | 182 | 2 | 22151770 | ||
| Pubmed | C4d-positive chronic rejection: a frequent entity with a poor outcome. | 2.72e-05 | 2 | 182 | 2 | 18091514 | |
| Pubmed | 2.72e-05 | 2 | 182 | 2 | 29080553 | ||
| Pubmed | 2.72e-05 | 2 | 182 | 2 | 6589636 | ||
| Pubmed | C4 Deficiency is a predisposing factor for Streptococcus pneumoniae-induced autoantibody production. | 2.72e-05 | 2 | 182 | 2 | 25339671 | |
| Pubmed | 2.72e-05 | 2 | 182 | 2 | 17728371 | ||
| Pubmed | 2.72e-05 | 2 | 182 | 2 | 6149580 | ||
| Pubmed | 2.72e-05 | 2 | 182 | 2 | 6149581 | ||
| Pubmed | 2.72e-05 | 2 | 182 | 2 | 12115608 | ||
| Pubmed | 2.72e-05 | 2 | 182 | 2 | 3542363 | ||
| Pubmed | 2.72e-05 | 2 | 182 | 2 | 2387317 | ||
| Pubmed | 2.72e-05 | 2 | 182 | 2 | 16908004 | ||
| Pubmed | 2.72e-05 | 2 | 182 | 2 | 7365238 | ||
| Pubmed | 2.72e-05 | 2 | 182 | 2 | 27655917 | ||
| Pubmed | Retinoic acid receptor-mediated induction of ABCA1 in macrophages. | 2.72e-05 | 2 | 182 | 2 | 14560020 | |
| Pubmed | 2.72e-05 | 2 | 182 | 2 | 7391573 | ||
| Pubmed | 2.72e-05 | 2 | 182 | 2 | 17971360 | ||
| Pubmed | 2.72e-05 | 2 | 182 | 2 | 17960519 | ||
| Pubmed | Clinical features of patients with homozygous complement C4A or C4B deficiency. | 2.72e-05 | 2 | 182 | 2 | 29928053 | |
| Pubmed | Analysis of C4 and the C4 binding protein in the MRL/lpr mouse. | 2.72e-05 | 2 | 182 | 2 | 17971229 | |
| Pubmed | 2.72e-05 | 2 | 182 | 2 | 6881182 | ||
| Pubmed | 2.72e-05 | 2 | 182 | 2 | 21564513 | ||
| Pubmed | Fluorescence-based imaging of autophagy progression by human WIPI protein detection. | 2.72e-05 | 2 | 182 | 2 | 25462558 | |
| Pubmed | Partial C4 deficiency in juvenile idiopathic arthritis patients. | 2.72e-05 | 2 | 182 | 2 | 17921792 | |
| Pubmed | 2.72e-05 | 2 | 182 | 2 | 21880985 | ||
| Pubmed | Amino acid sequence around the thiol and reactive acyl groups of human complement component C4. | 2.72e-05 | 2 | 182 | 2 | 6978711 | |
| Pubmed | 2.72e-05 | 2 | 182 | 2 | 35898513 | ||
| Pubmed | 2.72e-05 | 2 | 182 | 2 | 28873507 | ||
| Pubmed | 2.72e-05 | 2 | 182 | 2 | 276882 | ||
| Pubmed | Amino acid sequence of a polymorphic segment from fragment C4d of human complement component C4. | 2.72e-05 | 2 | 182 | 2 | 6832377 | |
| Pubmed | 2.72e-05 | 2 | 182 | 2 | 3794341 | ||
| Pubmed | 2.72e-05 | 2 | 182 | 2 | 22785613 | ||
| Pubmed | 2.72e-05 | 2 | 182 | 2 | 32691186 | ||
| Pubmed | The androgen-dependent C4-Slp gene is driven by a constitutively competent promoter. | 2.72e-05 | 2 | 182 | 2 | 8390682 | |
| Pubmed | Structure and expression of murine fourth complement component (C4) and sex-limited protein (Slp). | 2.72e-05 | 2 | 182 | 2 | 3902619 | |
| Pubmed | Structural polymorphism of murine C4 and its linkage to H-2. | 2.72e-05 | 2 | 182 | 2 | 7373044 | |
| Pubmed | The chemical structure of the C4d fragment of the human complement component C4. | 2.72e-05 | 2 | 182 | 2 | 3696167 | |
| Pubmed | Restriction fragment length polymorphism of the murine C4 and Slp genes: two C4 groups. | 2.72e-05 | 2 | 182 | 2 | 1357031 | |
| Pubmed | Structural comparison of human C4A3 and C4B1 after proteolytic activation by C1s. | 2.72e-05 | 2 | 182 | 2 | 16098595 | |
| Pubmed | WIPI β-propellers at the crossroads of autophagosome and lipid droplet dynamics. | 2.72e-05 | 2 | 182 | 2 | 25233424 | |
| GeneFamily | Collagens | 5.97e-07 | 46 | 121 | 6 | 490 | |
| GeneFamily | Phospholipases | 1.76e-04 | 42 | 121 | 4 | 467 | |
| GeneFamily | Aldehyde dehydrogenases | 2.62e-04 | 19 | 121 | 3 | 398 | |
| GeneFamily | Solute carriers | SLC24A5 SLC35E2B SLC30A2 SLC38A2 SLC30A5 SLC12A2 SLC24A4 SLC22A8 SLC37A2 SLC38A8 | 3.25e-04 | 395 | 121 | 10 | 752 |
| GeneFamily | WD repeat domain containing|UTPB complex | 6.55e-04 | 6 | 121 | 2 | 1225 | |
| GeneFamily | C3 and PZP like, alpha-2-macroglobulin domain containing | 1.55e-03 | 9 | 121 | 2 | 1234 | |
| GeneFamily | CD molecules|Integrin beta subunits | 1.55e-03 | 9 | 121 | 2 | 1159 | |
| GeneFamily | Complement system|Sushi domain containing | 1.78e-03 | 36 | 121 | 3 | 492 | |
| GeneFamily | WD repeat domain containing | 1.92e-03 | 262 | 121 | 7 | 362 | |
| GeneFamily | PDZ domain containing | 3.58e-03 | 152 | 121 | 5 | 1220 | |
| GeneFamily | Fibronectin type III domain containing | 4.45e-03 | 160 | 121 | 5 | 555 | |
| GeneFamily | Parkinson disease associated genes | 5.01e-03 | 16 | 121 | 2 | 672 | |
| Coexpression | NABA_COLLAGENS | 4.61e-07 | 43 | 179 | 6 | MM17060 | |
| Coexpression | NABA_COLLAGENS | 5.31e-07 | 44 | 179 | 6 | M3005 | |
| Coexpression | NABA_CORE_MATRISOME | VWA5B2 CRISPLD2 COL6A1 COL7A1 COL11A1 COL12A1 COL6A6 HAPLN1 AEBP1 LGI3 COL14A1 | 2.72e-06 | 270 | 179 | 11 | MM17057 |
| Coexpression | NABA_CORE_MATRISOME | VWA5B2 CRISPLD2 COL6A1 COL7A1 COL11A1 COL12A1 COL6A6 HAPLN1 AEBP1 LGI3 COL14A1 | 3.25e-06 | 275 | 179 | 11 | M5884 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HPERIC | CRISPLD2 COL6A1 NIBAN1 ABCA1 WIPI1 RARG UACA ING1 GPX8 PABPC4L EBF1 PPIB SLC38A2 MYOF SLC12A2 KLHL15 DCLK3 ALDH9A1 | 9.32e-06 | 795 | 179 | 18 | M39050 |
| Coexpression | MURARO_PANCREAS_MESENCHYMAL_STROMAL_CELL | CRISPLD2 KDELR2 COL6A1 ABCA1 HTRA1 WIPI1 COL12A1 HK1 UACA GPX8 EBF1 SLC38A2 MYOF AEBP1 G6PD SYNCRIP | 1.91e-05 | 681 | 179 | 16 | M39175 |
| Coexpression | SERVITJA_ISLET_HNF1A_TARGETS_UP | 2.03e-05 | 167 | 179 | 8 | M2395 | |
| Coexpression | NUYTTEN_EZH2_TARGETS_DN | CAD MIS18BP1 NEBL RPS3 POLD1 DLGAP5 POLR2G GLIS3 ITGA6 PAK6 NFU1 KCNV1 UTP18 SLC30A5 SLC12A2 ZNF587 MDC1 GPCPD1 PDZD8 WIPI2 | 2.46e-05 | 1023 | 179 | 20 | M17122 |
| Coexpression | LEE_BMP2_TARGETS_UP | CRISPLD2 COL6A1 COL7A1 ABCA1 HTRA1 WIPI1 HK1 LARP6 ACACB PPP1R9A PLXNB2 CRYL1 ALDH1A2 CCDC198 P2RX7 AEBP1 LIPG | 2.71e-05 | 780 | 179 | 17 | M2324 |
| Coexpression | LI_CISPLATIN_RESISTANCE_UP | 2.80e-05 | 26 | 179 | 4 | M4717 | |
| Coexpression | ZHANG_UTERUS_C2_SECRETORY_STROMAL3_RAMP3_HIGH_CELL | 2.97e-05 | 229 | 179 | 9 | MM16607 | |
| Coexpression | LEE_BMP2_TARGETS_UP | CRISPLD2 COL6A1 COL7A1 ABCA1 HTRA1 WIPI1 HK1 LARP6 ACACB PPP1R9A PLXNB2 CRYL1 ALDH1A2 CCDC198 P2RX7 AEBP1 LIPG | 4.01e-05 | 805 | 179 | 17 | MM1067 |
| Coexpression | SERVITJA_ISLET_HNF1A_TARGETS_UP | 4.23e-05 | 185 | 179 | 8 | MM1072 | |
| Coexpression | ZHANG_UTERUS_C1_PROLIFERATIVE_STROMAL1_MGP_HIGH_CELL | CRISPLD2 KDELR2 COL6A1 HTRA1 WIPI1 GPX8 EBF1 PPIB ALDH1A2 AEBP1 | 5.75e-05 | 310 | 179 | 10 | MM16608 |
| Coexpression | GSE21927_SPLEEN_VS_TUMOR_MONOCYTE_BALBC_DN | 5.91e-05 | 194 | 179 | 8 | M7580 | |
| Coexpression | BMI1_DN.V1_UP | 7.02e-05 | 147 | 179 | 7 | M2782 | |
| Coexpression | GSE17721_POLYIC_VS_CPG_8H_BMDC_DN | 7.07e-05 | 199 | 179 | 8 | M3947 | |
| Coexpression | GSE5589_UNSTIM_VS_180MIN_LPS_AND_IL10_STIM_MACROPHAGE_DN | 7.07e-05 | 199 | 179 | 8 | M6605 | |
| Coexpression | GSE40274_FOXP3_VS_FOXP3_AND_PBX1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN | 7.07e-05 | 199 | 179 | 8 | M9184 | |
| Coexpression | GSE369_PRE_VS_POST_IL6_INJECTION_IFNG_KO_LIVER_UP | 7.32e-05 | 200 | 179 | 8 | M5973 | |
| Coexpression | GSE13306_TREG_VS_TCONV_LAMINA_PROPRIA_UP | 7.32e-05 | 200 | 179 | 8 | M3220 | |
| Coexpression | GSE39864_WT_VS_GATA3_KO_TREG_DN | 7.32e-05 | 200 | 179 | 8 | M9063 | |
| Coexpression | CUI_DEVELOPING_HEART_COMPACT_VENTRICULAR_CARDIOMYOCYTE | 8.33e-05 | 65 | 179 | 5 | M39309 | |
| Coexpression | GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_UP | ALKBH4 PITPNM2 WIPI1 LRRC57 MAN2B1 CYP2F1 ACAD9 MYO1H RDH5 ITGA6 ALDH1L1 PLXNB2 OMP SLC12A2 RNPEP SLC37A2 PLA2G6 C4A C4B SCIN WIPI2 | 1.02e-04 | 1226 | 179 | 21 | MM979 |
| Coexpression | ZHANG_UTERUS_C0_SECRETORY_STROMAL3_NPPC_HIGH_CELL | CRISPLD2 KDELR2 COL6A1 HTRA1 WIPI1 GPX8 EBF1 PPIB HNRNPF ALDH1A2 | 1.14e-04 | 337 | 179 | 10 | MM16606 |
| Coexpression | GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_UP | ALKBH4 PITPNM2 WIPI1 LRRC57 MAN2B1 CYP2F1 ACAD9 MYO1H RDH5 ITGA6 ALDH1L1 PLXNB2 OMP SLC12A2 RNPEP SLC37A2 PLA2G6 C4B SCIN WIPI2 | 1.24e-04 | 1151 | 179 | 20 | M1103 |
| Coexpression | JECHLINGER_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP | 1.65e-04 | 75 | 179 | 5 | MM1143 | |
| Coexpression | WIERENGA_PML_INTERACTOME | 1.92e-04 | 42 | 179 | 4 | M2219 | |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_top-relative-expression-ranked_1000 | PAPPA2 CRISPLD2 COL6A1 COL11A1 HTRA1 COL12A1 MIS18BP1 POLR1A MYOM1 PABPC4L EBF1 SLC30A2 IKZF4 ALDH1A2 CCDC198 SLC12A2 AEBP1 LIPG DCLK3 COL14A1 WIPI2 | 3.58e-06 | 797 | 178 | 21 | gudmap_developingGonad_P2_epididymis_1000 |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_myocytic-stroma-myofibroblast|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | COL6A1 DPYS COL11A1 COL12A1 LARP6 RARG GPX8 HAPLN1 SCIN CDH15 | 8.31e-09 | 195 | 182 | 10 | 30ed961151b8b1f6ce37f06c9a061519f01c2864 |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | PITPNM2 FLNB FAT4 COL12A1 UACA PPP1R9A ITGA6 KIAA1217 KMT2A PRKCH | 1.06e-08 | 200 | 182 | 10 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb |
| ToppCell | facs-Pancreas-Endocrine-24m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.59e-08 | 179 | 182 | 9 | f14440f6ce9b4fcdd4bcb2488b949f9a0e17bc23 | |
| ToppCell | facs-Pancreas-Endocrine-24m-Mesenchymal|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.59e-08 | 179 | 182 | 9 | 6f51a4580c06fc55cc764052c9b26f7c55660282 | |
| ToppCell | facs-Pancreas-Endocrine-24m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.59e-08 | 179 | 182 | 9 | a6ce1fa338d4905bd6afef00763ac83e916a0b37 | |
| ToppCell | TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Infiltrating_Ductal_Carcinoma-6|TCGA-Breast / Sample_Type by Project: Shred V9 | 8.13e-08 | 187 | 182 | 9 | a96495803ba13fcfadd1d83b3cf5774f3fed0a20 | |
| ToppCell | facs-Lung-18m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l1|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.74e-08 | 191 | 182 | 9 | 2b73fcd592d16cae8ded5e45c8fbf2d9adc8caad | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.02e-07 | 192 | 182 | 9 | c07d7b40b2aa4eb27ac85801c014a656e2fd01dc | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.02e-07 | 192 | 182 | 9 | 04f5a2e3dd6beff027b89d66eefdd92036e041af | |
| ToppCell | facs-Lung-EPCAM-18m-Mesenchymal-Adventitial_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.06e-07 | 193 | 182 | 9 | 92048d2e9e43513e6185e09553be3ee47d7e5207 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Gen_Cap|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.06e-07 | 193 | 182 | 9 | af5108260783e69a7d67896c5bf64f862525926d | |
| ToppCell | Control-Endothelial-Endothelial-Gen_Cap|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | PITPNM2 FAT4 UACA PPP1R9A ITGA6 SHANK3 KIAA1217 GPCPD1 PRKCH | 1.06e-07 | 193 | 182 | 9 | e1d546165dcc2392f540162206852c4717d7306f |
| ToppCell | facs-Lung-EPCAM-18m-Mesenchymal-adventitial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.06e-07 | 193 | 182 | 9 | ac088c8f27b5b1888610e461ff45870ca60da886 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-Gen_Cap|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.06e-07 | 193 | 182 | 9 | e09387af84d2a0a526e54d4793e6e06c6739db53 | |
| ToppCell | droplet-Bladder-nan-3m|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | CRISPLD2 COL6A1 COL11A1 HTRA1 COL12A1 GPX8 ALDH1A2 AEBP1 COL14A1 | 1.06e-07 | 193 | 182 | 9 | e55f79bad6888b84b0ad5fccded498b170e3c6dc |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Gen_Cap|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.06e-07 | 193 | 182 | 9 | 6e1982d089a9de628e6006d23ff78a223fbd9f47 | |
| ToppCell | droplet-Bladder-nan-3m-Epithelial|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | CRISPLD2 COL6A1 COL11A1 HTRA1 COL12A1 GPX8 ALDH1A2 AEBP1 COL14A1 | 1.11e-07 | 194 | 182 | 9 | b294056f9bdc243263cf36dce7b62564144b9de1 |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Gen_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.11e-07 | 194 | 182 | 9 | 0b9cd96fa0b616da7cc90e92ff71157e9bba518f | |
| ToppCell | TCGA-Head_and_Esophagus-Primary_Tumor-Head_and_Neck_Carcinoma-Squamous_Cell_Carcinoma-8|TCGA-Head_and_Esophagus / Sample_Type by Project: Shred V9 | CRISPLD2 COL6A1 COL11A1 HTRA1 COL12A1 GPX8 AEBP1 DCLK3 CDH15 | 1.11e-07 | 194 | 182 | 9 | 55b97095a7a17a312c616703d291738a0f806339 |
| ToppCell | NS-critical-d_07-13-Epithelial-unknown_epithelial|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.23e-07 | 141 | 182 | 8 | 33ad925ff7be3c682741a6328216a89f9d4033e9 | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_osteo-stroma-osteoblast_precursor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.32e-07 | 198 | 182 | 9 | 9d61483b0decac2fe90045b3474843360b2c49b3 | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type | 1.38e-07 | 199 | 182 | 9 | fde2b65afde69f402f1b7b056eaa266e9fd5b227 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.38e-07 | 199 | 182 | 9 | 9846d6a31635fde759d55674631c11ab9270a603 | |
| ToppCell | Control_saline-Endothelial-Endothelial-Gen_Cap|Control_saline / Treatment groups by lineage, cell group, cell type | 1.44e-07 | 200 | 182 | 9 | 3b97920e1e6e2f09ddba2a861baa9c00c2970f4c | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.44e-07 | 200 | 182 | 9 | b2d4e6f3e8e4da62e6b02758ab2ed8f505269f9a | |
| ToppCell | COVID-19-Fibroblasts-Pathological_FB|COVID-19 / group, cell type (main and fine annotations) | 1.44e-07 | 200 | 182 | 9 | 73e01b7bc43320a991c67a4fd0c04708f893c7ea | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Transitional_Stromal_3_(C3+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.44e-07 | 200 | 182 | 9 | cfea2f9d85646c9b722150551ff2e8fc4f6cc98a | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Transitional_Stromal_3_(C3+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.44e-07 | 200 | 182 | 9 | 6f7f015b5fa1f52374f2c7d9ba339012395eda5f | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-fibroblastic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.44e-07 | 200 | 182 | 9 | 3a164e3971bcd62b148b813171c103adb81f972e | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.92e-07 | 169 | 182 | 8 | c0824a93674e2bff0f09b2d2fab5bab016a2e379 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.92e-07 | 169 | 182 | 8 | 12bdc709bc000d7f9061ecd9fbd57233eaacb7e2 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.14e-07 | 174 | 182 | 8 | a9c6edf5c3fc119c24425f921c5566a8356c30fe | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_G2M|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.29e-07 | 178 | 182 | 8 | c77a1d1a9aef0ab51b4408b9e84f201219788ca2 | |
| ToppCell | PND01-03-samps-Mesenchymal-Myofibroblast|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 8.62e-07 | 182 | 182 | 8 | 812dac35b9aa05be48258082e007f6c00e7b4dd8 | |
| ToppCell | facs-Lung-EPCAM-24m-Mesenchymal-Adventitial_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.99e-07 | 183 | 182 | 8 | 63294d66e3ccf152ffe5d1237106764c14390b62 | |
| ToppCell | facs-Lung-EPCAM-24m-Mesenchymal-adventitial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.99e-07 | 183 | 182 | 8 | 7e5c467fd1b156b928f1611a12ab4affb9f714b7 | |
| ToppCell | facs-Thymus-Epithelium-24m-Mesenchymal-fibroblast|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.75e-07 | 185 | 182 | 8 | eaa54b76743628c89b4310be57b87fa92b75fd37 | |
| ToppCell | facs-Thymus-Epithelium-24m-Mesenchymal|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.75e-07 | 185 | 182 | 8 | ff38a15af3dec36d9993f06623591872b5d1da9a | |
| ToppCell | facs-Thymus-Epithelium-24m-Mesenchymal-fibroblast|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.75e-07 | 185 | 182 | 8 | f7f4c921d248c637351e2e882589b99ba7f04b66 | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_adipo|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.06e-06 | 187 | 182 | 8 | f1d0fc625e0e7881b3f290742fd7148d995eb71e | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_adipo-stroma|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.06e-06 | 187 | 182 | 8 | 02e7246ef5ad41773d14426254e139b156d45c1d | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_adipo-stroma-adipo-CAR|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.06e-06 | 187 | 182 | 8 | 08c73d125e0638c9e9878165bba2442c266c8a48 | |
| ToppCell | COPD-Epithelial-Mesothelial|Epithelial / Disease state, Lineage and Cell class | 1.10e-06 | 188 | 182 | 8 | 159d63ecc3653a7449fc6acefd6ef0464845260e | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.15e-06 | 189 | 182 | 8 | 1821ae4a6e37ee4c6308071883f3f447a7c53c53 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.15e-06 | 189 | 182 | 8 | 1e4d7e8dc98b3d70351e6a6c2aaf9ca01f141b8f | |
| ToppCell | droplet-Lung-LUNG-1m-Mesenchymal-adventitial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.15e-06 | 189 | 182 | 8 | f0a2d4ef9896d764971ebbc6952510c128bb76e8 | |
| ToppCell | droplet-Lung-LUNG-1m-Mesenchymal-Adventitial_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.15e-06 | 189 | 182 | 8 | 378f26f751ab4b470948c35dd8347de72dd12ff7 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Mesenchymal|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.15e-06 | 189 | 182 | 8 | 1dc415ed41815f4296dafd8cf7f3e014c44db1db | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.15e-06 | 189 | 182 | 8 | 2a22b9fae70afb3dab8476f9c00e48a4df756410 | |
| ToppCell | droplet-Lung-nan-18m-Mesenchymal-adventitial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.19e-06 | 190 | 182 | 8 | 72c2b824acdc43139e6635785df3ed3feb58ec46 | |
| ToppCell | droplet-Lung-nan-18m-Mesenchymal-Adventitial_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.19e-06 | 190 | 182 | 8 | 97772e69e6f51ebffbb5433ca7b40f1048723220 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.24e-06 | 191 | 182 | 8 | b13229bb7f3713a392271aaf5dbae3edd1b9fe5a | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_myocytic|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.24e-06 | 191 | 182 | 8 | cc9a6a8fad17d6e1a08a68ab7512ae06b1249051 | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_myocytic-stroma|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.24e-06 | 191 | 182 | 8 | c16b920ee69ea8536e020ac3475abf1ce972c1e6 | |
| ToppCell | PND07-28-samps-Mesenchymal-Myofibroblast|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 1.24e-06 | 191 | 182 | 8 | 9bbafdf316c1fa3a9f1ee30d41dd7158b5c97279 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.24e-06 | 191 | 182 | 8 | 75d2197076a9dfc868e8baf95bd4c5e44f438e3e | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_fibro-stroma-endosteal_fibroblast|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.24e-06 | 191 | 182 | 8 | 44b1f62fdee03b157fe545f2ae6ff84f8929a8ac | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-3|TCGA-Ovary / Sample_Type by Project: Shred V9 | 1.24e-06 | 191 | 182 | 8 | 80d30d8eedb4c70b58440646325bc04c5700803e | |
| ToppCell | droplet-Lung-30m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l1|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.24e-06 | 191 | 182 | 8 | 24dc77ee8de01b42559f92721655f4281b114e17 | |
| ToppCell | droplet-Lung-1m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l1|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.29e-06 | 192 | 182 | 8 | c3707243c5590d852c9f28429c96f50a1fa6b0dc | |
| ToppCell | facs-Trachea-24m-Mesenchymal-fibroblast|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.29e-06 | 192 | 182 | 8 | fc940f91ff8e051631dbf25e6e8d73cf8337eccb | |
| ToppCell | facs-Pancreas-Exocrine-3m-Mesenchymal|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.29e-06 | 192 | 182 | 8 | e4a7f2673f801b008ca67291db2fb2b9fd2955b8 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.29e-06 | 192 | 182 | 8 | 3d0cb19f037f604253d7d728689aeaa94251e92b | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.29e-06 | 192 | 182 | 8 | ee085e04d5dcfb657522484ed20b8c1ddeccfe0c | |
| ToppCell | droplet-Lung-1m-Mesenchymal-fibroblast-adventitial_fibroblast|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.29e-06 | 192 | 182 | 8 | f9fb24457999dc9e751a099d7f995543b9330ad4 | |
| ToppCell | facs-Trachea-24m-Mesenchymal|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.29e-06 | 192 | 182 | 8 | e8af6ad1ae99cae13a82d0d8d7f38af9b777f0ba | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.29e-06 | 192 | 182 | 8 | 6f4ef24dab544681304b7f8a9dc073e7edaa4cf5 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.29e-06 | 192 | 182 | 8 | 8937a59f6bbe07f671bdabbd3707dc9c17a14cd9 | |
| ToppCell | LPS_only-Stromal_mesenchymal|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.29e-06 | 192 | 182 | 8 | 162d8b5858d150ecbbd1c9bf2b19c6c9cd50a158 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.29e-06 | 192 | 182 | 8 | ac1477433704573f95111eee6263b93668d2845e | |
| ToppCell | facs-Trachea-24m-Mesenchymal-fibroblast-fibroblast_of_trachea|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.29e-06 | 192 | 182 | 8 | 7a2e79490e4f7058bb76b46c45b5df9f729e3146 | |
| ToppCell | Epithelial-club_cell|World / Lineage, Cell type, age group and donor | 1.34e-06 | 193 | 182 | 8 | 2bdd09004fa433550958ec42ba4b06271a4aaf7c | |
| ToppCell | facs-Heart-RV-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.34e-06 | 193 | 182 | 8 | ff901d2f3d7a511639c1e3b76058896c0d8a8602 | |
| ToppCell | facs-Heart-RV-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.34e-06 | 193 | 182 | 8 | 735a72fac16397edde95e8eefa6f83caeb5ee5df | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.34e-06 | 193 | 182 | 8 | 02f633b016ab19bfa65bfd0cf32f000549a62148 | |
| ToppCell | Control-Endothelial-Endothelial|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.34e-06 | 193 | 182 | 8 | aff0649c73c634bc6ff0dc7759b4693a9236bf05 | |
| ToppCell | Control-Endothelial|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.34e-06 | 193 | 182 | 8 | c5f9fe03e64c211d4bcd4959e5b32f14841e336a | |
| ToppCell | LPS-antiTNF-Endothelial|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.34e-06 | 193 | 182 | 8 | 5122b1ffba42de190061be34ecdc6176f84e56a3 | |
| ToppCell | droplet-Lung-18m-Mesenchymal-fibroblast-adventitial_fibroblast|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.34e-06 | 193 | 182 | 8 | fe9720185929ef849edd1b8eb4854306b392e5a2 | |
| ToppCell | facs-Lung-24m-Mesenchymal-fibroblast-adventitial_fibroblast|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.34e-06 | 193 | 182 | 8 | e27885a9e1a2a3e165c5366d4cfcda05c5454483 | |
| ToppCell | droplet-Heart-nan-3m-Mesenchymal-fibroblast|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.39e-06 | 194 | 182 | 8 | ce32e60bcea1b8baf496ce9050832bc8c77d8434 | |
| ToppCell | nucseq-Mesenchymal-Myocytic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.39e-06 | 194 | 182 | 8 | 2d66091097e106c7bee22e5281f50724700bdf8d | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.39e-06 | 194 | 182 | 8 | 6e13549f697f7478b34fe71f7dd9d63c5d3db22e | |
| ToppCell | droplet-Lung-18m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l1|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.39e-06 | 194 | 182 | 8 | 5594f7437448cb4b37d2d100f44d30c4a367df26 | |
| ToppCell | droplet-Heart-nan-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.39e-06 | 194 | 182 | 8 | a1dc157148885cc8d3685ac81a1f4e3562aeecc9 | |
| ToppCell | facs-Lung-24m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l1|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.39e-06 | 194 | 182 | 8 | c9e589fe7df6a9b377654581a2aebb607cbb03b9 | |
| ToppCell | ASK428-Mesenchymal|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.45e-06 | 195 | 182 | 8 | 2b156163975d9a3d3fda1402acd9831d0fdc9e25 | |
| ToppCell | ASK428-Mesenchymal-Fibroblast|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.45e-06 | 195 | 182 | 8 | c269c0d894a0f55da6495b59d4b9abb9f68df684 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.45e-06 | 195 | 182 | 8 | f54bc4454270ff06e85596f98199372b50d0179f | |
| ToppCell | droplet-Bladder-nan-3m-Epithelial-bladder_cell|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.50e-06 | 196 | 182 | 8 | f47e551ba484687ba6ce8c29a085106131364042 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.50e-06 | 196 | 182 | 8 | 545d2e4469924d333e3f655f559c899fa1260196 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.56e-06 | 197 | 182 | 8 | fdb92985f7df0c280b87d3e43c2394e70786a2c7 | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-mesenchymal-mesenchymal-mesenchymal_stem_cell|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.56e-06 | 197 | 182 | 8 | 3bb92dd8a94e2be3b7fe51c9a21b241215477ac7 | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-mesenchymal|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.56e-06 | 197 | 182 | 8 | 17344464fdcc5ba0c03959696b97c195f11e644c | |
| ToppCell | COVID-19-Fibroblasts-Intermediate_pathological_FB|COVID-19 / group, cell type (main and fine annotations) | 1.56e-06 | 197 | 182 | 8 | f1c8936986123a3151140c374fcd62d6705c530b | |
| ToppCell | droplet-Bladder-BLADDER-1m-Epithelial|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.56e-06 | 197 | 182 | 8 | 036c4c9b3ae80e2dc21c24a84504d3da0541f945 | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-mesenchymal-mesenchymal|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.56e-06 | 197 | 182 | 8 | 5b8d0d7116b20d8e27541e88ec80c9f1f477e384 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_myocytic|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.62e-06 | 198 | 182 | 8 | 55d2ed345101bec4b73f1242ba8c4d73073b7e88 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.62e-06 | 198 | 182 | 8 | 1b90d632e59c3c47b936e829cceeb0334f05f34f | |
| ToppCell | Fibroblasts-DKK3+_Fibroblasts|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 1.62e-06 | 198 | 182 | 8 | 4f4632f26a2043c5e4ab89031b4229b5dca1bd48 | |
| Drug | Madecassol | 1.52e-06 | 46 | 178 | 6 | CID000108062 | |
| Drug | glycerol | CAD HK1 POLR1A MAOA MYOM1 GPX8 NTRK1 POLR2G APCS NCF4 ADGRV1 ITGB7 EFTUD2 CRYL1 ALDH1A2 LIPG PLA2G6 PRKCH HAL PLD2 G6PD | 2.25e-06 | 829 | 178 | 21 | CID000000753 |
| Drug | AC1L1C2F | 2.48e-06 | 110 | 178 | 8 | CID000001711 | |
| Drug | Nitrarine dihydrochloride [20069-05-0]; Down 200; 10.6uM; PC3; HT_HG-U133A | 3.62e-06 | 197 | 178 | 10 | 3683_DN | |
| Drug | Diclofenac sodium [15307-79-6]; Up 200; 12.6uM; PC3; HT_HG-U133A | 3.78e-06 | 198 | 178 | 10 | 5861_UP | |
| Drug | coenzyme 1 | HK1 MAOA RDH5 NCF4 ALDH1L1 PAK6 NDUFB6 RYR1 CRYL1 ALDH1A2 P2RX7 XYLB HAL ALDH9A1 ART5 G6PD CYB5R1 | 4.74e-06 | 596 | 178 | 17 | CID000000925 |
| Drug | GK-101 | 8.55e-06 | 36 | 178 | 5 | CID000161853 | |
| Drug | Clemizole hydrochloride [1163-36-6]; Down 200; 11uM; PC3; HT_HG-U133A | 2.20e-05 | 193 | 178 | 9 | 3672_DN | |
| Drug | AGEPC | NCF4 ITGB2 PLA2G15 IKZF4 HAPLN1 PLA2G6 PRKCH C4A PLCG2 HAL PLD2 ART5 | 2.52e-05 | 356 | 178 | 12 | CID000461545 |
| Drug | Nitrarine dihydrochloride [20069-05-0]; Up 200; 10.6uM; MCF7; HT_HG-U133A | 2.59e-05 | 197 | 178 | 9 | 6043_UP | |
| Drug | Glipizide [29094-61-9]; Down 200; 9uM; PC3; HT_HG-U133A | 2.80e-05 | 199 | 178 | 9 | 6645_DN | |
| Drug | UTP-NA | CAD HK1 POLR1A POLD1 POLR2G PMVK P2RX7 RBM6 PLA2G6 PLCG2 PLD2 ART5 ENTPD8 | 2.81e-05 | 420 | 178 | 13 | CID000001181 |
| Drug | Benzamil hydrochloride [2898-76-2]; Up 200; 11.2uM; HL60; HT_HG-U133A | 2.92e-05 | 200 | 178 | 9 | 2200_UP | |
| Drug | strontium ranelate | 3.14e-05 | 77 | 178 | 6 | CID006918182 | |
| Disease | cutaneous melanoma, hair color | 1.63e-06 | 62 | 171 | 6 | EFO_0000389, EFO_0003924 | |
| Disease | obsolete_red blood cell distribution width | KDELR2 AHI1 WIPI1 HK1 CYP2C18 POLR1A ZCCHC8 NTRK1 HECTD4 FREM3 KSR1 SLC12A2 LIPG KIAA1217 NT5C2 RBM6 ELAVL2 PLA2G6 G6PD TBL2 CDH15 USP47 | 1.18e-05 | 1347 | 171 | 22 | EFO_0005192 |
| Disease | body weight | PAPPA2 COL11A1 POLR1A EPHA6 PARK7 HECTD4 EBF1 ADGRV1 SIM1 PAK6 SPATA31C1 SLC38A2 ALDH1A2 UTP18 SLC12A2 SLC24A4 KIAA1217 ELAVL2 SYT4 PLA2G6 PCM1 | 1.42e-05 | 1261 | 171 | 21 | EFO_0004338 |
| Disease | response to carboplatin, response to antineoplastic agent | 2.23e-05 | 10 | 171 | 3 | GO_0097327, GO_0097328 | |
| Disease | free cholesterol in small HDL measurement | 4.96e-05 | 35 | 171 | 4 | EFO_0022270 | |
| Disease | lipoprotein measurement, phospholipid measurement | 1.39e-04 | 85 | 171 | 5 | EFO_0004639, EFO_0004732 | |
| Disease | phosphoglycerides measurement | 1.74e-04 | 48 | 171 | 4 | EFO_0022291 | |
| Disease | metabolic syndrome | 1.74e-04 | 200 | 171 | 7 | EFO_0000195 | |
| Disease | nevus count, cutaneous melanoma | 1.92e-04 | 91 | 171 | 5 | EFO_0000389, EFO_0004632 | |
| Disease | Ullrich congenital muscular dystrophy | 1.99e-04 | 4 | 171 | 2 | cv:C4551860 | |
| Disease | Bethlem myopathy | 1.99e-04 | 4 | 171 | 2 | cv:C1834674 | |
| Disease | BETHLEM MYOPATHY 1 | 1.99e-04 | 4 | 171 | 2 | C1834674 | |
| Disease | Ullrich congenital muscular dystrophy 1 | 1.99e-04 | 4 | 171 | 2 | C0410179 | |
| Disease | chronic obstructive pulmonary disease, interleukin-8 measurement | 1.99e-04 | 4 | 171 | 2 | EFO_0000341, EFO_0004811 | |
| Disease | Bethlem myopathy (is_implicated_in) | 1.99e-04 | 4 | 171 | 2 | DOID:0050663 (is_implicated_in) | |
| Disease | Ullrich congenital muscular dystrophy (is_implicated_in) | 1.99e-04 | 4 | 171 | 2 | DOID:0050558 (is_implicated_in) | |
| Disease | cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement | 2.19e-04 | 276 | 171 | 8 | EFO_0004612, EFO_0020943 | |
| Disease | phospholipids in medium HDL measurement | 2.95e-04 | 55 | 171 | 4 | EFO_0022295 | |
| Disease | Psychotic Disorders | 3.12e-04 | 101 | 171 | 5 | C0033975 | |
| Disease | osteoarthritis | 3.28e-04 | 222 | 171 | 7 | MONDO_0005178 | |
| Disease | arecaidine measurement | 3.30e-04 | 5 | 171 | 2 | EFO_0801112 | |
| Disease | choline measurement, phosphatidylcholine measurement | 3.30e-04 | 5 | 171 | 2 | EFO_0010116, EFO_0010226 | |
| Disease | congenital nonspherocytic hemolytic anemia (is_implicated_in) | 3.30e-04 | 5 | 171 | 2 | DOID:2861 (is_implicated_in) | |
| Disease | atopy | 3.30e-04 | 5 | 171 | 2 | EFO_0002686 | |
| Disease | total lipids in medium HDL measurement | 3.62e-04 | 58 | 171 | 4 | EFO_0022310 | |
| Disease | free cholesterol in medium HDL measurement | 3.62e-04 | 58 | 171 | 4 | EFO_0022267 | |
| Disease | free cholesterol in HDL measurement | 4.39e-04 | 61 | 171 | 4 | EFO_0022264 | |
| Disease | phospholipids in HDL measurement | 4.39e-04 | 61 | 171 | 4 | EFO_0022293 | |
| Disease | apolipoprotein A 1 measurement | PAPPA2 PITPNM2 COL7A1 ABCA1 ACACB MYO1H EBF1 PKD1L3 ALDH1A2 LIPG RBM6 KMT2A SYT4 PLA2G6 | 4.46e-04 | 848 | 171 | 14 | EFO_0004614 |
| Disease | metabolite measurement | SLC24A5 DPYS COL11A1 PYROXD2 ALDH1L1 SLC38A2 MYOF ALDH1A2 RNPEP ALDH9A1 G6PD | 4.49e-04 | 560 | 171 | 11 | EFO_0004725 |
| Disease | Alzheimer disease, high density lipoprotein cholesterol measurement | 4.51e-04 | 26 | 171 | 3 | EFO_0004612, MONDO_0004975 | |
| Disease | panic disorder (is_implicated_in) | 4.93e-04 | 6 | 171 | 2 | DOID:594 (is_implicated_in) | |
| Disease | total lipids in HDL measurement | 4.97e-04 | 63 | 171 | 4 | EFO_0022307 | |
| Disease | total lipids in very large HDL measurement | 5.93e-04 | 66 | 171 | 4 | EFO_0022312 | |
| Disease | phospholipid measurement, high density lipoprotein cholesterol measurement | 5.97e-04 | 321 | 171 | 8 | EFO_0004612, EFO_0004639 | |
| Disease | cerebral infarction (is_implicated_in) | 6.25e-04 | 29 | 171 | 3 | DOID:3526 (is_implicated_in) | |
| Disease | omega-3 polyunsaturated fatty acid measurement | 6.36e-04 | 118 | 171 | 5 | EFO_0010119 | |
| Disease | Schizophrenia | ABCA1 AHI1 HK1 MAOA NTRK1 SHANK3 SLC38A2 ALDH1A2 SLC12A2 TPH2 KMT2A ELAVL2 PLA2G6 PCM1 | 6.63e-04 | 883 | 171 | 14 | C0036341 |
| Disease | Angle Closure Glaucoma | 6.88e-04 | 7 | 171 | 2 | C0017605 | |
| Disease | cutaneous melanoma | 7.13e-04 | 121 | 171 | 5 | EFO_0000389 | |
| Disease | phospholipids in large HDL measurement | 8.68e-04 | 73 | 171 | 4 | EFO_0022190 | |
| Disease | docosahexaenoic acid measurement | 8.87e-04 | 127 | 171 | 5 | EFO_0007761 | |
| Disease | total lipids in large HDL | 9.14e-04 | 74 | 171 | 4 | EFO_0022189 | |
| Disease | pantothenate measurement | 9.14e-04 | 8 | 171 | 2 | EFO_0021034 | |
| Disease | memory impairment | 9.14e-04 | 8 | 171 | 2 | EFO_0001072 | |
| Disease | Varicose veins | 9.43e-04 | 193 | 171 | 6 | HP_0002619 | |
| Disease | triglyceride measurement, response to diuretic | 1.00e-03 | 34 | 171 | 3 | EFO_0004530, GO_0036270 | |
| Disease | free cholesterol in large HDL measurement | 1.17e-03 | 79 | 171 | 4 | EFO_0022157 | |
| Disease | Depression, Bipolar | 1.17e-03 | 79 | 171 | 4 | C0005587 | |
| Disease | reticulocyte count | PITPNM2 FLNB ABCA1 WIPI1 HK1 ZCCHC8 HECTD4 EBF1 PLXNB2 NT5C2 PLA2G6 C4B TMEM131 PLCG2 WIPI2 | 1.17e-03 | 1045 | 171 | 15 | EFO_0007986 |
| Disease | low tension glaucoma | 1.17e-03 | 9 | 171 | 2 | EFO_1001022 | |
| Disease | cholesterol in small HDL measurement | 1.19e-03 | 36 | 171 | 3 | EFO_0022226 | |
| Disease | Intellectual Disability | 1.25e-03 | 447 | 171 | 9 | C3714756 | |
| Disease | reticulocyte measurement | PITPNM2 FLNB ABCA1 WIPI1 HK1 ZCCHC8 HECTD4 EBF1 PLXNB2 SLC12A2 NT5C2 RBM6 TMEM131 PLCG2 WIPI2 | 1.26e-03 | 1053 | 171 | 15 | EFO_0010700 |
| Disease | hair colour measurement, eye colour measurement, skin pigmentation measurement | 1.46e-03 | 10 | 171 | 2 | EFO_0007009, EFO_0007822, EFO_0009764 | |
| Disease | fasting blood glucose measurement | 1.48e-03 | 287 | 171 | 7 | EFO_0004465 | |
| Disease | Disorder of eye | 1.53e-03 | 212 | 171 | 6 | C0015397 | |
| Disease | obesity (implicated_via_orthology) | 1.64e-03 | 215 | 171 | 6 | DOID:9970 (implicated_via_orthology) | |
| Disease | serum alanine aminotransferase measurement | COL12A1 ZCCHC8 HECTD4 ALDH1L1 PLXNB2 FCSK ALDH1A2 P2RX7 NYNRIN SEPTIN14 RBM6 PLA2G6 TBL2 | 1.73e-03 | 869 | 171 | 13 | EFO_0004735 |
| Disease | primary angle closure glaucoma | 1.77e-03 | 11 | 171 | 2 | EFO_1001506 | |
| Disease | pigmentation disease (is_implicated_in) | 1.77e-03 | 11 | 171 | 2 | DOID:10123 (is_implicated_in) | |
| Disease | diabetic nephropathy, type 2 diabetes mellitus | 1.77e-03 | 11 | 171 | 2 | EFO_0000401, MONDO_0005148 | |
| Disease | Enzymopathy | 1.77e-03 | 11 | 171 | 2 | C0520572 | |
| Disease | lipid measurement, lipoprotein measurement | 1.89e-03 | 90 | 171 | 4 | EFO_0004529, EFO_0004732 | |
| Disease | eye color | 1.89e-03 | 90 | 171 | 4 | EFO_0003949 | |
| Disease | glaucoma | 2.08e-03 | 154 | 171 | 5 | MONDO_0005041 | |
| Disease | hair colour measurement, hair morphology measurement | 2.12e-03 | 12 | 171 | 2 | EFO_0007821, EFO_0007822 | |
| Disease | Congenital muscular dystrophy | 2.12e-03 | 12 | 171 | 2 | cv:C0699743 | |
| Disease | phospholipids:total lipids ratio, high density lipoprotein cholesterol measurement | 2.16e-03 | 307 | 171 | 7 | EFO_0004612, EFO_0020946 | |
| Disease | central corneal thickness | 2.24e-03 | 309 | 171 | 7 | EFO_0005213 | |
| Disease | saturated fatty acids measurement | 2.27e-03 | 45 | 171 | 3 | EFO_0022304 | |
| Disease | hair color | 2.33e-03 | 311 | 171 | 7 | EFO_0003924 | |
| Disease | free cholesterol measurement, high density lipoprotein cholesterol measurement | 2.50e-03 | 315 | 171 | 7 | EFO_0004612, EFO_0008591 | |
| Disease | total cholesterol measurement, high density lipoprotein cholesterol measurement | 2.50e-03 | 315 | 171 | 7 | EFO_0004574, EFO_0004612 | |
| Disease | alcohol consumption measurement, high density lipoprotein cholesterol measurement | 2.59e-03 | 162 | 171 | 5 | EFO_0004612, EFO_0007878 | |
| Disease | triglyceride measurement, alcohol drinking | 2.67e-03 | 99 | 171 | 4 | EFO_0004329, EFO_0004530 | |
| Disease | total lipids in lipoprotein particles measurement | 2.73e-03 | 48 | 171 | 3 | EFO_0022309 | |
| Disease | triglyceride measurement, alcohol consumption measurement | 2.87e-03 | 101 | 171 | 4 | EFO_0004530, EFO_0007878 | |
| Disease | triglyceride measurement, low density lipoprotein cholesterol measurement | 2.88e-03 | 166 | 171 | 5 | EFO_0004530, EFO_0004611 | |
| Disease | reading and spelling ability | 2.88e-03 | 166 | 171 | 5 | EFO_0005301 | |
| Disease | Hepatic fibrosis | 2.90e-03 | 49 | 171 | 3 | HP_0001395 | |
| Disease | glucose-dependent insulinotropic peptide measurement, glucose tolerance test | 2.90e-03 | 14 | 171 | 2 | EFO_0004307, EFO_0008464 | |
| Disease | anemia (is_implicated_in) | 2.90e-03 | 14 | 171 | 2 | DOID:2355 (is_implicated_in) | |
| Disease | low density lipoprotein cholesterol measurement, alcohol drinking | 2.98e-03 | 102 | 171 | 4 | EFO_0004329, EFO_0004611 | |
| Disease | cholesteryl esters:total lipids ratio, high density lipoprotein cholesterol measurement | 3.02e-03 | 243 | 171 | 6 | EFO_0004612, EFO_0020944 | |
| Disease | alcohol drinking, high density lipoprotein cholesterol measurement | 3.03e-03 | 168 | 171 | 5 | EFO_0004329, EFO_0004612 | |
| Disease | non-high density lipoprotein cholesterol measurement | ABCA1 HK1 MYO1H GLIS3 SIM1 ALDH1A2 LIPG NYNRIN GPCPD1 PLA2G6 HYDIN | 3.07e-03 | 713 | 171 | 11 | EFO_0005689 |
| Disease | pulse pressure measurement | PAPPA2 COL6A1 FLNB COL11A1 NEBL ING1 EBF1 SLC35E2B PKD1L3 PLXNB2 FCSK SLC12A2 KIAA1217 NT5C2 SYT4 HYDIN PCM1 | 3.08e-03 | 1392 | 171 | 17 | EFO_0005763 |
| Disease | lipid measurement, high density lipoprotein cholesterol measurement | 3.23e-03 | 330 | 171 | 7 | EFO_0004529, EFO_0004612 | |
| Disease | free cholesterol to total lipids in small HDL percentage | 3.25e-03 | 51 | 171 | 3 | EFO_0022285 | |
| Disease | lipoprotein measurement | 3.30e-03 | 105 | 171 | 4 | EFO_0004732 | |
| Disease | total lipids in LDL measurement | 3.43e-03 | 52 | 171 | 3 | EFO_0022308 | |
| Disease | total phospholipids in lipoprotein particles measurement | 3.62e-03 | 53 | 171 | 3 | EFO_0022315 | |
| Disease | triglycerides in HDL measurement | 3.62e-03 | 53 | 171 | 3 | EFO_0022317 | |
| Disease | hepatocellular carcinoma (biomarker_via_orthology) | 3.66e-03 | 108 | 171 | 4 | DOID:684 (biomarker_via_orthology) | |
| Disease | cup-to-disc ratio measurement | 3.73e-03 | 430 | 171 | 8 | EFO_0006939 | |
| Disease | treatment-resistant hypertension | 3.78e-03 | 109 | 171 | 4 | EFO_1002006 | |
| Disease | 4-acetamidobutanoate measurement | 3.80e-03 | 16 | 171 | 2 | EFO_0021003 | |
| Disease | gliosarcoma | 3.80e-03 | 16 | 171 | 2 | C0206726 | |
| Disease | autism spectrum disorder (is_implicated_in) | 3.80e-03 | 16 | 171 | 2 | DOID:0060041 (is_implicated_in) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KTEGFCGLPSFSREV | 121 | Q9NXW9 | |
| SGTEKAFEPATGRVI | 26 | P49189 | |
| VIEEFLATGEKLFGP | 266 | Q9H4A4 | |
| LKVVARGSFEFPVGD | 911 | P0C0L5 | |
| RGSFEFPVGDAVSKV | 916 | P0C0L5 | |
| ILVDARKPLFFGEGT | 286 | P49902 | |
| TGKVVGVFRPETVAS | 291 | Q13685 | |
| FGFTQTGIISIERKP | 1031 | Q8N157 | |
| GLGRKGFFIEPTVFS | 391 | O94788 | |
| TEFGTEVEPEFGTKV | 1091 | Q8IUX7 | |
| APKGTIVGEVFASDR | 3311 | Q6V0I7 | |
| AFVGGSKVVILDEPT | 1046 | O95477 | |
| KITAFIVERDFGGVT | 241 | Q9H845 | |
| GRTIISPAISGKDFV | 5546 | Q8WXG9 | |
| GKDFVITEGTLVFEP | 5556 | Q8WXG9 | |
| GKVRLFPSEAVIAEG | 481 | Q86SJ2 | |
| DVVVTDFRFGTIPVK | 86 | Q5VUY0 | |
| FLSPFSVPEARGDKV | 411 | Q8NFF2 | |
| GVDFFSRLLEIEPGK | 46 | Q14964 | |
| VGVDFFSRLVEIEPG | 41 | Q96DA2 | |
| VDVRVPGFGKTFSLE | 111 | Q8NCC3 | |
| IVEFAKRLPGFTGLS | 241 | P13631 | |
| AFRGFLIPKGTDVIT | 376 | P24903 | |
| ACVILTFKEPFGTEG | 231 | P11413 | |
| FLVTFGEGVEPANLK | 141 | P47874 | |
| TGVFQLKDRGLTEFP | 16 | Q8N9N7 | |
| SPAEFVTRFGGDRVI | 246 | O00763 | |
| PVGRIFFAGTETATK | 426 | P21397 | |
| VFFDITVDGKPLGRI | 6 | A0A0B4J2A2 | |
| KDETPFGVSVAVGLA | 411 | P04629 | |
| RVHTSFDPKEGKFVG | 21 | Q9NQU5 | |
| SGVRKEFPITEAVGS | 846 | Q6P0N0 | |
| TAPKVLFTGVVDARG | 1891 | Q14676 | |
| KTGDARIGFVGFPSV | 61 | Q9Y295 | |
| IEGVKSVFFGPDFIT | 106 | Q9UMS0 | |
| DEFGEGTVTRITPKG | 2226 | O95714 | |
| ESGSKPFTRQEVIGF | 171 | Q6ZP29 | |
| LLPTDIKFGIVFDAG | 36 | Q5MY95 | |
| FKERVGYREGPTVET | 21 | Q96AT1 | |
| FLPDGRSVVDTVGGK | 631 | Q17RB8 | |
| GVFSVTAGDGKFIPR | 451 | Q14117 | |
| GGDLFDAIIESVKFP | 436 | Q9C098 | |
| VGRSPVFLFEDHTGK | 131 | P12107 | |
| GTEIFVGKIPRDLFE | 161 | O60506 | |
| EKPGSSTAARIFGVI | 201 | Q6PIU1 | |
| GDIRPDTTTGKIVAF | 396 | Q6PIU1 | |
| VDTSRIKVFGPGIEG | 1226 | O75369 | |
| IPFAVRKGEITGEVH | 1751 | O75369 | |
| EGEVEKPFIKTGFSV | 1216 | Q15154 | |
| ETPFTGGVEVDVFGK | 866 | O15031 | |
| SSKVVPRFERFGLGV | 901 | Q8IVT5 | |
| RGPGTSFEFALAIVE | 156 | Q99497 | |
| RDVFLGETVPFIKTI | 146 | Q8NEN9 | |
| KSRIFPGDTILETGE | 101 | O95139 | |
| GLVDITRNGKVPFFV | 346 | Q9H0B8 | |
| TVRGATGIFPLSFVK | 211 | Q15080 | |
| FVKGTVGRITGLDPA | 181 | Q9Y5X9 | |
| FGTFGVISSVRILKP | 221 | Q9BRS8 | |
| VFIETGTARGVVGFK | 66 | Q6UWN0 | |
| FDVLISAAGGKFVPE | 211 | Q8TDZ2 | |
| GIVSKDEITFVSGAP | 306 | P23229 | |
| GKDGTFLVRESETFP | 556 | P16885 | |
| LPKGTEFVVFSIDGS | 1101 | Q9BZ72 | |
| GPIVSFGFTTEAEKR | 2011 | Q9Y4D8 | |
| TFVRSIPDGSEKGDF | 66 | P19367 | |
| LGFIFLESEGRPTKE | 11 | Q8N475 | |
| IGFGSFVDKTVLPFV | 191 | P26010 | |
| VFFDITVDGKPLGRI | 6 | A0A075B767 | |
| IGFGSFVDKTVLPFV | 166 | P05107 | |
| RAIFIFLTTDGLVPG | 1276 | Q9BXP8 | |
| VFFDITVDGKPLGRI | 6 | Q9Y536 | |
| IFFDITVDGKPLGRI | 6 | P0DN37 | |
| KVFGIRFDILVFGTG | 311 | Q99572 | |
| RGTREGPITEDFFKA | 171 | Q9Y2V7 | |
| DGRVPLVSGVVFFSV | 216 | Q8N0W3 | |
| ISFFGALRIPGVVEF | 286 | Q8TED4 | |
| PEKLSFRGEVQGVVS | 46 | Q9UKF2 | |
| DELGVFSLKGRPTTA | 3526 | Q4G0P3 | |
| ITTGFGKFARTVIPI | 166 | P42357 | |
| KREVPVASGSGFIVS | 196 | Q92743 | |
| VAFEIRGTLLPGEVF | 6 | Q9NPB8 | |
| SVPRSEFAVGVIGKF | 366 | Q96M94 | |
| VVSVGIKDVFDFIPG | 751 | P12109 | |
| FTESAGARVGFPKVA | 231 | Q99715 | |
| GARVGFPKVAIIITD | 236 | Q99715 | |
| TVTFEGPEIRKIFYG | 1341 | Q05707 | |
| VLGFGFVAGSEKPVV | 86 | Q14CM0 | |
| GISVPKGIRNIFEFT | 36 | Q8ND61 | |
| GLFKTERLEEFPGST | 271 | Q8NEA6 | |
| LFGFIPGSEDVKHIR | 251 | Q5JW98 | |
| KIVFDAGFFRVESPV | 606 | Q15398 | |
| AGFFRVESPVKLFSG | 611 | Q15398 | |
| KERLVTFSLDTFGPV | 476 | Q6TDU7 | |
| PVEIERTAFVGFVEK | 81 | Q9UH73 | |
| FGPFGAVTNVKVIRD | 296 | Q12926 | |
| SEGVFVVKDPNGRTV | 531 | O00754 | |
| IKGEVVPENGFEVFR | 1981 | Q03164 | |
| EVRSFLEGLVLPFSG | 56 | Q02388 | |
| GEEFSGRGSFPVAEK | 91 | P33260 | |
| FGPIPEFSRATAEKV | 266 | Q9Y2S2 | |
| GDPTKFGLGVFSIVF | 331 | O60931 | |
| PLLAERTVSGIFFGV | 151 | Q9NQC7 | |
| KILGSEGEPAFRFLV | 141 | Q8TED1 | |
| KEVETPSAGRVDFAF | 21 | Q9NVL8 | |
| IFGGVDVPAKFITIL | 361 | Q8TCC7 | |
| GGSVEFQFVPVLKLV | 1831 | P21817 | |
| GVDEEPRGVFSIDKF | 86 | P55291 | |
| SVPVLRAFGVTDEGF | 121 | P28340 | |
| DTFRVEFLVVPVGGL | 91 | P33947 | |
| VLRVVGESGEPVKAF | 516 | Q9H2S9 | |
| LKVVARGSFEFPVGD | 911 | P0C0L4 | |
| RGSFEFPVGDAVSKV | 916 | P0C0L4 | |
| EFPLGTFIGEKEISF | 1051 | A6NMZ7 | |
| LPSEASVDKIFGVIG | 2731 | Q8TE73 | |
| TPFKVLTGGESRLTE | 1756 | Q9P2P1 | |
| VTEDLLFRKFSTVGP | 21 | P0CB38 | |
| SPTEAAVRFVGFPDK | 326 | P10915 | |
| EGVVTKRSFPAIGVE | 696 | Q9UF33 | |
| DNVGPKVFVGESFIV | 1066 | P0C091 | |
| RGLPFGCTKEEIVQF | 116 | P52597 | |
| FDEIPTVVGIFSAFG | 11 | Q9H2B2 | |
| EKIVRSFEVSPDGSF | 341 | Q9Y5J1 | |
| TIERPAFGIQKGEFE | 321 | P78332 | |
| FISFIKSPEGGEELV | 91 | A5PLK6 | |
| RFEKVFESAVDPGAV | 56 | Q8N4H0 | |
| LFFTAKEPSRVTGLE | 196 | Q9UGK8 | |
| VTGRFLTGIKPPEFF | 951 | O95602 | |
| GLLPFAVVGSTDEVK | 241 | Q6ZU15 | |
| NKTGRFVIEEIPGEF | 621 | Q9Y6U3 | |
| SPATFGRGFIAVAVI | 131 | Q9UK53 | |
| DPQKTVFERGGLDVF | 781 | Q7Z443 | |
| DVGRVIFGLFGKTVP | 56 | P23284 | |
| QTLDGFIFVVAPDGK | 86 | P81133 | |
| VGEAVATLKGEFPTL | 761 | Q5T5P2 | |
| AVVQKRFGFPEGSVE | 71 | P23396 | |
| SEKGTVIRVFSIPEG | 221 | Q9Y4P8 | |
| DFGETPTFLASKIGR | 381 | O60733 | |
| FPGKVLGATSEESER | 541 | P0DKV0 | |
| KAGGVVPAFLVELVS | 51 | A6NNN8 | |
| DSLKVGDVVEFRGPS | 136 | Q9UHQ9 | |
| VPFSKDTVSDVGVGL | 496 | Q6NSI8 | |
| ADPGFFCRKIVEGIS | 86 | Q15126 | |
| FGIRVSIVEPGFFRT | 196 | Q92781 | |
| FTKDDGILGTFPAER | 41 | Q9Y2V3 | |
| EGAVPTIFESFSKLR | 86 | Q9BT49 | |
| PDVRKIGFTGSTEVG | 641 | O75891 | |
| GDDGTIFVVPKLSEF | 1191 | Q9BXT8 | |
| EKGPLTFRDVVIEFS | 31 | Q8NE65 | |
| AEEVEERFGRFKPGV | 276 | Q6NZY4 | |
| RQVGATVEFTVGDKP | 141 | Q13432 | |
| SSTVFDPVFKVRGII | 56 | Q13156 | |
| GPVSSGFSEVRVLFE | 356 | Q9BZQ8 | |
| VFRPFKGEVVDAVVT | 76 | P62487 | |
| TDLSGKVFVFPRESV | 21 | P02743 | |
| GFGFVLRGAKAETPI | 581 | Q9BYB0 | |
| GAAVTEEIIPGFKFS | 71 | Q8N2H3 | |
| APGFKDSVVGRDILT | 491 | Q8N2H3 | |
| VPTIRDIFGFIGASA | 431 | Q96QD8 | |
| VFREFGKDVLPSSGL | 171 | Q96SQ5 | |
| EAVLLRGTTVAPGFK | 146 | Q92670 | |
| IGDFVIGTFIPLESK | 446 | P55011 | |
| RKILPGGNTSFDVVF | 161 | Q92545 | |
| SPQLKEFFRGGEVTR | 116 | Q9NRS6 | |
| EFFRGGEVTRPLEVS | 121 | Q9NRS6 | |
| LAGGTDVPFSEVVKL | 481 | O75191 | |
| VFREFGKDVLPSSGL | 171 | Q8TAU3 | |
| EFAKGRGTFPCDISV | 1271 | Q96K76 | |
| PELVTAFLGVFITKG | 121 | Q71RS6 | |
| FFTDVPVIGRSGKSF | 276 | P0CK96 | |
| FLKERSGFTVRPVAG | 266 | Q8IWU9 | |
| SGVVGVKVPQFSFSR | 1256 | P27708 | |
| PGKLDVEGRSVFHVV | 61 | Q9BZF9 | |
| APFKVGALSTEVLGR | 731 | Q8N398 | |
| GPAKTRGAAFFIIAV | 146 | Q8TAD4 | |
| ARGFVVLPITEFLVG | 121 | Q8N3G9 | |
| EKGTVIRVFSVPDGQ | 206 | Q5MNZ9 | |
| FFVPGDRQVVIGTKT | 461 | Q9UNX4 | |
| LFTEQERGVGIKSTP | 171 | Q15029 | |
| FDPGFEVQVGKRSTE | 261 | O14939 | |
| GTERVDPGFEGVTLK | 136 | P0C6A0 | |
| GRFVASCGFTPDVKV | 241 | Q9Y4P3 | |
| GIFVPFLRAGSEVLT | 51 | Q2T9J0 | |
| GTPKGVDFTAVRDLL | 231 | Q9BRI3 | |
| PEGKVFVVITLTGSF | 126 | P24723 | |
| FVDGEGKPRLIVSSS | 381 | Q8N145 | |
| EVVFRGVGSLRFEPK | 156 | Q96L15 | |
| FISPGKEGTIVFDTG | 996 | Q8N1T3 | |
| VGKDEFLGRSIFSPV | 1221 | Q9NZM1 | |
| GRTPVTGYFVDLKEA | 1066 | P52179 | |
| FVIGREKPGQVSEVA | 586 | Q9ULJ8 | |
| HEDFEKTKGRGFTPV | 786 | O76041 |